Royal London Asset Management Ltd. Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Royal London Asset Management Ltd. decreased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 1.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 304,010 shares of the real estate investment trust’s stock after selling 5,402 shares during the period. Royal London Asset Management Ltd.’s holdings in Healthpeak Properties were worth $6,162,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in DOC. Harvest Fund Management Co. Ltd purchased a new stake in Healthpeak Properties during the 4th quarter worth about $30,000. Avior Wealth Management LLC acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $37,000. Groupama Asset Managment acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $37,000. Wiser Advisor Group LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at approximately $42,000. Finally, Continuum Advisory LLC purchased a new position in shares of Healthpeak Properties during the third quarter valued at approximately $44,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on DOC shares. StockNews.com raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday. Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Wedbush decreased their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Wells Fargo & Company lowered their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Finally, Scotiabank cut their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $20.02 on Monday. The firm has a fifty day moving average of $20.24 and a 200-day moving average of $21.16. Healthpeak Properties, Inc. has a 52-week low of $17.45 and a 52-week high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $14.00 billion, a P/E ratio of 57.19, a PEG ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a $0.305 dividend. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.10%. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.